Company Overview and News

 
3 Boring Companies Ready To Outperform

2018-09-24 seekingalpha
Boring companies are being offered at fair value, but they offer potential without the crazy risks that come with hot darling stocks that everyone is chasing.
BRC YELP BRY

3
Capitol Report: As Yelp keeps accusing Google of bias, it’s singing a tune that could resonate with Trump

2018-09-24 marketwatch
Mid-cap reviews company continually blasts the search titan’s practices as biased — and Big Tech is now dealing with a somewhat similar criticism from conservatives
GOOGL YELP NYTAB GOOG

3
Yelp (YELP) Catches Eye: Stock Jumps 6.8%

2018-09-21 zacks
Yelp, Inc. (YELP - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company — as the stock is now up 16.9% in the past one-month time frame.
TTGT EVLV YELP MLAB

1
Here's Why You Should Hold Grubhub Stock in Your Portfolio

2018-09-20 zacks
Grubhub (GRUB - Free Report) earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering an average positive earnings surprise of 25.6%. With expected long-term earnings per share growth rate of 25% and a market cap of $12.99 billion, it seems to be a stock that investors should keep in their portfolio for now. Let’s take a look at the factors that have been driving the company’s performance.
GRPN YUM YELP GRUB

11
Tencent-backed Meituan climbs 5 percent on debut, brightens outlook for HK IPOs

2018-09-20 channelnewsasia
Meituan Dianping climbed on debut in Hong Kong on Thursday, valuing the Chinese online food delivery-to-ticketing services firm at about US$55 billion and sending a positive signal to companies lining up to list in the financial hub.
BABA GRPN YELP 0700 TRI

11
UPDATE 4-Tencent-backed Meituan climbs 5 pct on debut, brightens outlook for HK IPOs

2018-09-20 reuters
HONG KONG (Reuters) - Meituan Dianping (3690.HK) rose 5 percent on debut in Hong Kong on Thursday, valuing the Chinese online food delivery-to-ticketing services firm at about $55 billion and sending a positive signal to companies lining up to list in the financial hub.
BABA GRPN YELP 0700

11
Tencent-backed Meituan jumps 5 percent on debut, brightens outlook for HK IPOs

2018-09-20 channelnewsasia
Meituan Dianping climbed on debut in Hong Kong on Thursday, valuing the Chinese online food delivery-to-ticketing services firm at about US$55 billion and sending a positive signal to companies lining up to list in the financial hub.
GRPN BABA YELP 0700 TRI MS

11
UPDATE 3-Tencent-backed Meituan jumps 5 pct on debut, brightens outlook for HK IPOs

2018-09-20 reuters
HONG KONG (Reuters) - Meituan Dianping (3690.HK) climbed on debut in Hong Kong on Thursday, valuing the Chinese online food delivery-to-ticketing services firm at about $55 billion and sending a positive signal to companies lining up to list in the financial hub.
GRPN BABA YELP 0700 MS

 
Focus: As its trading debut looms, China's Meituan locked in battle of super-apps

2018-09-17 channelnewsasia
Meituan Dianping, which raised US$4.2 billion in its Hong Kong IPO, is one of China's super-apps, with 340 million users ordering groceries, paying bills, renting bikes and booking hotels - but it is far from alone.
YELP 0700

 
As its trading debut looms, China's Meituan locked in battle of super-apps

2018-09-17 channelnewsasia
BEIJING: Meituan Dianping, which raised US$4.2 billion in its Hong Kong IPO, is one of China's super-apps, with 340 million users ordering groceries, paying bills, renting bikes and booking hotels: but it is far from alone.
YELP 0700

 
As its trading debut looms, China's Meituan locked in battle of super-apps

2018-09-17 reuters
BEIJING/SHANGHAI (Reuters) - Meituan Dianping, which raised $4.2 billion in its Hong Kong IPO, is one of China’s super-apps, with 340 million users ordering groceries, paying bills, renting bikes and booking hotels - but it is far from alone.
YELP 0700

 
As its trading debut looms, China’s Meituan locked in battle of super-apps

2018-09-17 malaymail
BEIJING, Sept 17 — Meituan Dianping, which raised US$4.2 billion (RM17.3 billion) in its Hong Kong IPO, is one of China’s super-apps, with 340 million users ordering groceries, paying bills, renting bikes and booking hotels — but it is far from alone.
YELP 0700

1
Grubhub Completes LevelUp Buyout, Set to Buy OrderUp Assets

2018-09-14 zacks
Grubhub (GRUB - Free Report) recently completed the acquisition of LevelUp, which manages digital ordering and payment solutions for national and regional restaurants, for $390 million in cash. LevelUp has a customer base comprising the likes of Roti, Pret a Manger, Zaxby's and Just Salad, among others. The acquisition will add more than 200 customers with robust point-of-sale integrations. Grubhub expects the LevelUp transaction to contribute revenues of approximately $2 million to third-quarter results.
GRPN YUM CY YELP GRUB

28
Top Analyst Upgrades and Downgrades: Adobe, Corning, Costco, GrubHub, Kroger, Micron, Shopify, SLM, Walmart, Yelp and More

2018-09-14 247wallst
Stocks were indicated to open marginally higher on Friday, but not so much that the direction of this day looked set. U.S. equity indexes remain near all-time highs at a time that most international markets are not close to their highs. One issue that stands out to U.S. investors is that they have seen less upside from buying on market pullbacks than in prior years. Investors also need to consider how they want to have their investments positioned for the rest of 2018.
WFCNP YELP ADBE WMT WFC GLW ANGI COST GRUB DHI DNKN TRI

6
UPDATE 2-Trump's antitrust enforcer considers shifting up a gear

2018-09-13 reuters
WASHINGTON (Reuters) - The chairman of the Federal Trade Commission, which stops mergers it believes will push up prices, signaled Thursday he was willing to consider tougher enforcement, a move that could affect high profile big tech companies but also energy producers, drug makers and a big swath of the U.S. economy.
FB PX GOOGL YELP TWX GOOG TWC

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

5h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

CUSIP: 985817105